Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1279-1285

  Wang, Yang ^a   Dong, Qianze ^a   Zhang, Qingfu ^a   Li, Zixuan ^a   Wang, Enhua ^a   Qiu, Xueshan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; PROTEIN KINASE YES;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN TARGETING; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROGNOSIS; TRANSCRIPTION FACTORS;

EID: 77953197857     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01511.x     Document Type: Article

References (28)

1. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002, 1:49-52.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
3. Schiller JH, Harrington D, Belani CP. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-8.
4. Dong J, Feldmann G, Huang J. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-33.
5. Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005, 122:421-34.
6. Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell 2006, 124:267-73.
7. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 1999, 18:2551-62.
8. Strano S, Monti O, Pediconi N. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 2005, 18:447-59.
9. Howell M, Borchers C, Milgram SL. Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription. J Biol Chem 2004, 279:26300-6.
10. Zaidi SK, Sullivan AJ, Medina R. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 2004, 23:790-9.
11. Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 2003, 278:33334-41.
12. Espanel X, Sudol M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem 2001, 276:14514-23.
13. Strano S, Munarriz E, Rossi M. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 2001, 276:15164-73.
14. Morin-Kensicki EM, Boone BN, Howell M. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 2006, 26:77-87.
15. Zender L, Spector MS, Xue W. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125:1253-67.
16. Overholtzer M, Zhang J, Smolen GA. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 2006, 103:12405-10.
17. Modena P, Lualdi E, Facchinetti F. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 2006, 24:5223-33.
18. Steinhardt AA, Gayyed MF, Klein AP. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008, 39:1582-9.
19. Xu MZ, Yao TJ, Lee NP. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009, 115:4576-85.
20. Zhao B, Wei X, Li W. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007, 21:2747-61.
21. Camargo FD, Gokhale S, Johnnidis JB. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007, 17:2054-60.
22. Danovi SA, Rossi M, Gudmundsdottir K, Yuan M, Melino G, Basu S. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ 2008, 15:217-9.
23. West AB, Kapatos G, O'Farrell C. N-myc regulates parkin expression. J Biol Chem 2004, 279:28896-902.
24. Gu Y, Wang C, Wang Y, Qiu X, Wang E. Expression of thymosin beta10 and its role in non-small cell lung cancer. Hum Pathol 2009, 40:117-24.
25. Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008, 14:388-98.
26. Yuan M, Tomlinson V, Lara R. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008, 15:1752-9.
27. Matallanas D, Romano D, Yee K. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 2007, 27:962-75.
28. Santos SD, Verveer PJ, Bastiaens PI. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007, 9:324-30.